Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experiment.

Gutierrez JI, Montgomery ET, Dilworth SE, McNulty MC, Colasanti JA, Johnson MO, Koester KA, Sauceda JA, Erguera XA, Dance K, Tsuzuki MD, Hickey MD, Kerkhoff AD, Neilands TB, Eshun-Wilson I, Geng E, Christopoulos KA, MODERN ART Study Group